mucofalk orange 3,25 g/5 g granulas
dr. falk pharma gmbh, germany - olveida ceļctekas sēklsedze - granulas - 3,25 g/5 g
strattera 60 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 60 mg
strattera 18 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 18 mg
strattera 40 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 40 mg
strattera 25 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 25 mg
strattera 80 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 80 mg
strattera 10 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 10 mg
strattera 100 mg cietās kapsulas
eli lilly nederland b.v., netherlands - atomoeksetīns - kapsula, cietā - 100 mg
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.